Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) FCF Margin (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed FCF Margin for 16 consecutive years, with 0.02% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 1821.0% to 0.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10.86% through Dec 2025, up 1265.0% year-over-year, with the annual reading at 10.86% for FY2025, 1265.0% up from the prior year.
  • FCF Margin hit 0.02% in Q4 2025 for Cumberland Pharmaceuticals, down from 1.97% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 47.42% in Q2 2023 to a low of 25.63% in Q1 2024.
  • Historically, FCF Margin has averaged 11.8% across 5 years, with a median of 11.17% in 2023.
  • Biggest five-year swings in FCF Margin: crashed -5618bps in 2024 and later surged 5851bps in 2025.
  • Year by year, FCF Margin stood at 23.45% in 2021, then surged by 77bps to 41.56% in 2022, then tumbled by -74bps to 10.6% in 2023, then soared by 72bps to 18.23% in 2024, then crashed by -100bps to 0.02% in 2025.
  • Business Quant data shows FCF Margin for CPIX at 0.02% in Q4 2025, 1.97% in Q3 2025, and 7.54% in Q2 2025.